These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17925731)

  • 1. [Gastrointestinal carcinoid tumors: a multi-technique diagnostic approach].
    Mathonnet M
    J Chir (Paris); 2007; 144(4):287-92. PubMed ID: 17925731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal carcinoids: the evolution of diagnostic strategies.
    Modlin IM; Latich I; Zikusoka M; Kidd M; Eick G; Chan AK
    J Clin Gastroenterol; 2006 Aug; 40(7):572-82. PubMed ID: 16917396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
    Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
    Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography (PET) in neuroendocrine gastrointestinal tumors.
    Eriksson B; Bergström M; Lilja A; Ahlström H; Långström B; Oberg K
    Acta Oncol; 1993; 32(2):189-96. PubMed ID: 7686763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of chromogranin A levels and somatostatin receptor scintigraphy findings in the evaluation of metastases in carcinoid tumors.
    Namwongprom S; Wong FC; Tateishi U; Kim EE; Boonyaprapa S
    Ann Nucl Med; 2008 May; 22(4):237-43. PubMed ID: 18535873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated plasma chromogranin A is the first indication of recurrence in radically operated midgut carcinoid tumors.
    Welin S; Stridsberg M; Cunningham J; Granberg D; Skogseid B; Oberg K; Eriksson B; Janson ET
    Neuroendocrinology; 2009; 89(3):302-7. PubMed ID: 19176944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract.
    Rorstad O
    J Surg Oncol; 2005 Mar; 89(3):151-60. PubMed ID: 15719376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioiodinated metaiodobenzylguanidine in the diagnosis and therapy of carcinoid tumors.
    Khan MU; Morse M; Coleman RE
    Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):441-54. PubMed ID: 19088697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal carcinoids: characterization by site of origin and hormone production.
    Onaitis MW; Kirshbom PM; Hayward TZ; Quayle FJ; Feldman JM; Seigler HF; Tyler DS
    Ann Surg; 2000 Oct; 232(4):549-56. PubMed ID: 10998653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standard imaging techniques for neuroendocrine tumors.
    Bushnell DL; Baum RP
    Endocrinol Metab Clin North Am; 2011 Mar; 40(1):153-62, ix. PubMed ID: 21349416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of PET in neuroendocrine tumors. In vivo applications and in vitro studies.
    Eriksson B; Bergström M; Orlefors H; Sundin A; Oberg K; Långström B
    Q J Nucl Med; 2000 Mar; 44(1):68-76. PubMed ID: 10932603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of 11C-5-hydroxy-tryptophan positron emission tomography in neuroendocrine tumor diagnosis and management: experience from one center.
    Nikolaou A; Thomas D; Kampanellou C; Alexandraki K; Andersson LG; Sundin A; Kaltsas G
    J Endocrinol Invest; 2010 Dec; 33(11):794-9. PubMed ID: 20332708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.
    Koopmans KP; Neels OC; Kema IP; Elsinga PH; Sluiter WJ; Vanghillewe K; Brouwers AH; Jager PL; de Vries EG
    J Clin Oncol; 2008 Mar; 26(9):1489-95. PubMed ID: 18349401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoid tumors of the gastrointestinal tract.
    Ghevariya V; Malieckal A; Ghevariya N; Mazumder M; Anand S
    South Med J; 2009 Oct; 102(10):1032-40. PubMed ID: 19738517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoid tumours.
    Tiensuu Janson EM; Oberg KE
    Baillieres Clin Gastroenterol; 1996 Dec; 10(4):589-601. PubMed ID: 9113314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoid syndrome: diagnosis and medical management.
    van der Lely AJ; de Herder WW
    Arq Bras Endocrinol Metabol; 2005 Oct; 49(5):850-60. PubMed ID: 16444370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoid tumors: imaging procedures and interventional radiology.
    Wallace S; Ajani JA; Charnsangavej C; DuBrow R; Yang DJ; Chuang VP; Carrasco CH; Dodd GD
    World J Surg; 1996 Feb; 20(2):147-56. PubMed ID: 8661810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of neuroendocrine tumours with [111In] DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging.
    Shi W; Johnston CF; Buchanan KD; Ferguson WR; Laird JD; Crothers JG; McIlrath EM
    QJM; 1998 Apr; 91(4):295-301. PubMed ID: 9666953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catecholamine-secreting metastatic carcinoid as differential diagnosis in pheochromocytoma: clinical, laboratory, and imaging clues in the search for the lurking neuroendocrine tumor (NET).
    Whitman HH; Fishman EK; Oberg K; Wildman JM; Long AL
    Ann N Y Acad Sci; 2006 Aug; 1073():59-78. PubMed ID: 17102073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromogranin A as an alternative to 5-hydroxyindoleacetic acid in the evaluation of symptoms during treatment of patients with neuroendocrine Tumors.
    Korse CM; Bonfrer JM; Aaronson NK; Hart AA; Taal BG
    Neuroendocrinology; 2009; 89(3):296-301. PubMed ID: 18840995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.